Pfizer's PR Review in Final Stages

Inspiration meets innovation at Brandweek, the ultimate marketing experience. Join industry luminaries, rising talent and strategic experts in Phoenix, Arizona this September 23–26 to assess challenges, develop solutions and create new pathways for growth. Register early to save.

BOSTON Pfizer’s search for an agency holding company to handle public relations duties for its cardiovascular drug treatment franchise is in the final stages.

In November, the New York-based client invited WPP, Interpublic Group and Omnicom to each assemble public relations teams to pitch the account. Since then, Omnicom has dropped out of the competition. The reason for that departure is undisclosed.

Pfizer has begun hearing pitches, and a decision will be made by the end of January, according to a company representative.



AW+

WORK SMARTER - LEARN, GROW AND BE INSPIRED.

Spring Special

Save 30% Off an ADWEEK Subscription Today!

View Your Options

Already a member? Sign in